Lonza News Nov 25, 2025 Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook By Investing.com - Investing.com South Africa
Endpoints News Nov 25, 2025 FDA OKs Sarepta study of new immune suppression approach with Elevidys; Gilead buys preclinical TREX1 program
Endpoints News Nov 25, 2025 Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial
PLoS Biology Nov 25, 2025 Episodic memory involves transient and sparse connectivity aligned to both internal and external events
PLoS Biology Nov 25, 2025 The novel GlcNAc 6-phosphate dehydratase NagS governs a metabolic checkpoint that controls nutrient signaling in <i>Streptomyces</i>